tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
RenovoRx Reports Revenue Growth and Trial Progress
PremiumCompany AnnouncementsRenovoRx Reports Revenue Growth and Trial Progress
2M ago
RenovoRx Reports Strong Q2 2025 Revenue Growth
Premium
Company Announcements
RenovoRx Reports Strong Q2 2025 Revenue Growth
2M ago
Meet RenovoRx: Fly exclusive interview with CEO Shaun Bagai
Premium
The Fly
Meet RenovoRx: Fly exclusive interview with CEO Shaun Bagai
2M ago
RenovoRx Stockholders Approve Key Proposals at Annual Meeting
PremiumCompany AnnouncementsRenovoRx Stockholders Approve Key Proposals at Annual Meeting
3M ago
RenovoRx price target raised to $11.50 from $11 at Ascendiant
Premium
The Fly
RenovoRx price target raised to $11.50 from $11 at Ascendiant
4M ago
RenovoRx Buy Rating: Promising RenovoCath Adoption and TIGeR-PaC Study Progress Drive Positive Outlook
Premium
Ratings
RenovoRx Buy Rating: Promising RenovoCath Adoption and TIGeR-PaC Study Progress Drive Positive Outlook
4M ago
RenovoRx reports Q1 EPS (8c), consensus (8c)
PremiumThe FlyRenovoRx reports Q1 EPS (8c), consensus (8c)
5M ago
RenovoRx announces Johns Hopkins initiated for TIGeR-PaC Phase 3 trial
Premium
The Fly
RenovoRx announces Johns Hopkins initiated for TIGeR-PaC Phase 3 trial
5M ago
RenovoRx Reports Initial Revenue and Clinical Trial Progress
Premium
Company Announcements
RenovoRx Reports Initial Revenue and Clinical Trial Progress
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100